212 related articles for article (PubMed ID: 8815166)
1. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Masuda K; Kato M
J Neurol Sci; 1996 Mar; 136(1-2):169-73. PubMed ID: 8815166
[TBL] [Abstract][Full Text] [Related]
2. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
[TBL] [Abstract][Full Text] [Related]
3. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
4. 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.
Nagasawa H; Saito H; Kogure K; Hatazawa J; Itoh M; Fujiwara T; Watanuki S; Seo S; Iwata R; Ido T
J Neurol Sci; 1993 Apr; 115(2):136-43. PubMed ID: 8482975
[TBL] [Abstract][Full Text] [Related]
5. Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography.
Nagasawa H; Tanji H; Itoyama Y; Saito H; Kimura I; Fujiwara T; Iwata R; Itoh M; Ido T
J Neurol Sci; 1996 Dec; 144(1-2):70-6. PubMed ID: 8994106
[TBL] [Abstract][Full Text] [Related]
6. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
7. Detection of preclinical Parkinson's disease with PET.
Brooks DJ
Neurology; 1991 May; 41(5 Suppl 2):24-7; discussion 28. PubMed ID: 1904139
[TBL] [Abstract][Full Text] [Related]
8. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
[TBL] [Abstract][Full Text] [Related]
9. Detection of preclinical Parkinson's disease with PET.
Brooks DJ
Geriatrics; 1991 Aug; 46 Suppl 1():25-30. PubMed ID: 1909983
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
[TBL] [Abstract][Full Text] [Related]
11. Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease.
Pikstra ARA; van der Hoorn A; Leenders KL; de Jong BM
Neuroimage Clin; 2016; 11():68-72. PubMed ID: 26909330
[TBL] [Abstract][Full Text] [Related]
12. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D
J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
[TBL] [Abstract][Full Text] [Related]
14. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Morrish PK; Rakshi JS; Bailey DL; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):314-9. PubMed ID: 9527140
[TBL] [Abstract][Full Text] [Related]
15. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
16. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
[TBL] [Abstract][Full Text] [Related]
17. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
[TBL] [Abstract][Full Text] [Related]
18. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
19. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
Burn DJ; Brooks DJ
Neurology; 1993 Mar; 43(3 Pt 1):552-6. PubMed ID: 8451000
[TBL] [Abstract][Full Text] [Related]
20. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
Hoshi H; Kuwabara H; Léger G; Cumming P; Guttman M; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):57-69. PubMed ID: 8417011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
